Clinical trial
Effects of Levosimendan in Acute Kidney Injury After Cardiac Surgery
NCT02531724 is registered in ClinicalTrials.gov with Sahlgrenska University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects of Levosimendan in Acute Kidney Injury After Cardiac Surgery
- Lead sponsor
- Sahlgrenska University Hospital
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- September 30, 2015
- Completion date
- December 31, 2020
- Enrollment
- 30 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
acute kidney injury, renal insufficiency, acute